Years Active: 2009
Title: Joseph Sparano: Innovator in Cancer Research
Introduction: Joseph Sparano is a notable inventor based in Pleasantville, NY (US). He has made significant contributions to the field of cancer research, particularly in understanding gene expression and its implications for cancer treatment. Although he currently holds no granted patents, his work has the potential to impact the medical community significantly.
Latest Patent Applications: Joseph Sparano has filed several patent applications that focus on critical advancements in cancer treatment. One of his latest applications is titled "Gene Expression Markers of Recurrence Risk in Cancer Patients After Chemotherapy." This invention relates to genes whose expression levels are correlated with the likelihood of breast cancer recurrence in patients after tumor resection and chemotherapy. Another application is for a "Method for Determining the Likelihood of Response to HER2 Inhibitors," which provides methods for determining the HER2 status of a cancer tumor sample.
Conclusion: Joseph Sparano's innovative work in cancer research highlights the importance of understanding genetic factors in treatment responses. His contributions, although not yet reflected in granted patents, pave the way for future advancements in oncology.